Vilon: Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides →
📌TL;DR
- •2 community protocols documented
- •Evidence level: Anecdotal Reports
- •Based on 15 community reports
- •2 stacking patterns reported
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Evidence Base | All published Vilon research originates from the Khavinson group. Studies show immunomodulatory effects, lifespan extension in CBA mice, chromatin reactivation (deheterochromatinization) in aged lymphocytes, and anti-tumor effects. No independent replication or Western clinical trials exist. | Community uses Vilon as part of the broader Khavinson bioregulator paradigm. Most users obtain oral capsule formulations. Community reports are very limited due to the niche nature of this compound. | high Vilon has one of the thinnest evidence bases of any peptide on this site. All research is from a single group, with no independent replication or regulatory validation outside of Russia. |
| Oral Bioavailability | As a simple dipeptide (Lys-Glu), Vilon is theoretically capable of oral absorption. Khavinson's research suggests oral bioregulatory peptides can modulate gene expression, though formal PK studies demonstrating oral bioavailability are limited. | Community primarily uses oral capsules, accepting the bioregulator paradigm that short peptides are orally bioavailable and capable of gene regulatory effects at low doses. | moderate While a dipeptide has a better chance of surviving GI transit than larger peptides, formal demonstration of oral bioavailability and biological activity after oral dosing is limited. |
Compare these community approaches with published research findings.
Community Protocols
Oral Bioregulator Capsule Protocol
Common- Route
- Oral
- Dose
- 1-2 capsules daily
- Frequency
- 1-2 times daily with meals
- Duration
- 10-30 days, repeated every 4-6 months
Most accessible form; available as capsules from bioregulator suppliers, following standard Khavinson cycling
Subcutaneous Injection Protocol
Niche- Route
- Subcutaneous
- Dose
- 100-500 mcg
- Frequency
- Once daily
- Duration
- 10-20 days
Injectable form for potentially more reliable delivery; doses very low given the dipeptide simplicity
Stacking Patterns
Vilon + Epitalon + Thymalin Bioregulator Stack
NicheComprehensive Khavinson bioregulator protocol targeting cellular health (Vilon), pineal/telomere function (Epitalon), and immune restoration (Thymalin)
Check stack compatibility and review potential side effects before combining peptides.
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 15+ self-experimenters report. Free with email.
150+ peptide profiles · 30+ comparisons · 18 research tools
Sources
- Reddit r/Peptides|Vilon/KE dipeptide bioregulator discussions (limited)(accessed 2026-02-16)
- Reddit r/Nootropics|Khavinson bioregulator peptide discussions including Vilon(accessed 2026-02-16)
- Bioregulators.info|Khavinson Peptide Bioregulators interactive guide including Vilon(accessed 2026-02-16)
- Biohacking News|Bioregulator Peptides - Russian Anti-Aging Discovery Explained(accessed 2026-02-16)
Community Evidence Overview#
This page presents information about Vilon (KE dipeptide) in the context of community peptide use. This is not clinical evidence and should not be used as medical guidance.
Vilon is one of the simplest compounds in the Khavinson bioregulator peptide family, consisting of just two amino acids (Lys-Glu). Community interest is driven primarily by the broader bioregulator paradigm rather than Vilon-specific research, as the evidence base for this dipeptide is very thin even by bioregulator standards.
Understanding Protocol Divergence#
Minimal Evidence Base#
Vilon has one of the thinnest evidence bases of any peptide covered on this site. All published research originates from the Khavinson group, with no independent replication. The primary claims (immunomodulation, lifespan extension in mice, chromatin reactivation) are interesting but unverified by external researchers.
Dipeptide Bioactivity Question#
A fundamental scientific question underlies Vilon use: can a simple dipeptide produce meaningful biological effects when taken orally at low doses? While Khavinson's bioregulator theory proposes that short peptides interact directly with DNA to modulate gene expression, this concept has not been broadly validated.
Commonly Reported Outcomes#
Community reports for Vilon are very limited. The few available accounts describe subtle or no noticeable effects, consistent with a compound whose mechanism of action (if real) would be expected to produce gradual, long-term changes rather than acute effects.
Important Caveats#
- All research comes from a single group with no independent replication
- The dipeptide bioactivity paradigm is not widely validated
- Community reports are extremely sparse
- As a simple dipeptide (Lys-Glu), product identity verification is challenging
Related Reading#
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles · 30+ comparisons · 18 research tools
Frequently Asked Questions About Vilon
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.